ClearPoint Neuro (CLPT) Other Accumulated Expenses (2011 - 2026)
ClearPoint Neuro recorded quarterly Other Accumulated Expenses of $2.1 million in Q1 2026, down 23.73% quarter-over-quarter from $2.8 million in Q4 2025, and up 40.73% year-over-year from $1.5 million in Q1 2025.
ClearPoint Neuro's Other Accumulated Expenses history runs 16 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- In Q1 2026, Other Accumulated Expenses rose 40.73% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (up 40.73% YoY), while the FY2025 annual figure was $2.8 million, up 92.14% from the prior year.
- Other Accumulated Expenses came in at $2.1 million for Q1 2026 at ClearPoint Neuro, down from $2.8 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $2.8 million in Q4 2025 to a low of $602000.0 in Q1 2022.
- A 5-year average of $1.4 million and a median of $1.3 million in 2024 frame the typical range for Other Accumulated Expenses.
- Across the five-year window, Other Accumulated Expenses jumped 284.54% in 2022 and sank 49.01% in 2023, its largest moves.
- ClearPoint Neuro's Other Accumulated Expenses stood at $2.1 million in 2022, then plunged by 49.01% to $1.1 million in 2023, then jumped by 37.7% to $1.4 million in 2024, then jumped by 92.14% to $2.8 million in 2025, then slipped by 23.73% to $2.1 million in 2026.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $2.1 million, $2.8 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.13 Mn |
| Dec 31, 2025 | 2.79 Mn |
| Sep 30, 2025 | 1.75 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.51 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 986,000.00 |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 953,000.00 |
| Jun 30, 2023 | 1.37 Mn |
| Mar 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | 2.07 Mn |
| Sep 30, 2022 | 1.25 Mn |
| Jun 30, 2022 | 870,000.00 |
| Mar 31, 2022 | 602,000.00 |
| Dec 31, 2021 | 537,000.00 |
| Sep 30, 2021 | 1.08 Mn |
| Jun 30, 2021 | 892,000.00 |
| Mar 31, 2021 | 473,000.00 |
| Dec 31, 2020 | 349,000.00 |
| Sep 30, 2020 | 487,768.00 |
| Jun 30, 2020 | 334,627.00 |
| Mar 31, 2020 | 411,491.00 |
| Dec 31, 2019 | 328,000.00 |
| Sep 30, 2019 | 403,054.00 |
| Jun 30, 2019 | 382,872.00 |
| Mar 31, 2019 | 319,654.00 |
| Dec 31, 2018 | 390,838.00 |
| Sep 30, 2018 | 252,820.00 |
| Jun 30, 2018 | 378,912.00 |
| Mar 31, 2018 | 359,270.00 |
| Dec 31, 2017 | 480,159.00 |
| Dec 31, 2016 | 450,424.00 |
| Sep 30, 2016 | 539,659.00 |
| Jun 30, 2016 | 718,223.00 |
| Mar 31, 2016 | 1.31 Mn |
| Dec 31, 2015 | 1.40 Mn |
| Sep 30, 2015 | 1.09 Mn |
| Jun 30, 2015 | 1.14 Mn |
| Mar 31, 2015 | 328,842.00 |
| Dec 31, 2014 | 1.30 Mn |
| Sep 30, 2014 | 1.02 Mn |
| Jun 30, 2014 | 909,591.00 |
| Mar 31, 2014 | 526,800.00 |
| Dec 31, 2013 | 310,317.00 |
| Sep 30, 2013 | 373,635.00 |
| Jun 30, 2013 | 332,055.00 |
| Mar 31, 2013 | 348,124.00 |
| Dec 31, 2012 | 1.18 Mn |
| Sep 30, 2012 | 6.24 Mn |
| Jun 30, 2012 | 1.71 Mn |
| Mar 31, 2012 | 1.79 Mn |
| Dec 31, 2011 | 2.02 Mn |